Immediate Impact
25 standout
Citing Papers
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
2024 Standout
Principles and therapeutic applications of adaptive immunity
2024 Standout
Works of Vasily Shuvaev being referenced
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase
2018
Treatment-Free Remission in Patients with Chronic Myeloid Leukemia in Chronic Phase According to Reasons for Switching from Imatinib to Nilotinib: Subgroup Analysis from ENESTop
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Vasily Shuvaev | 194 | 206 | 95 | 51 | 229 | |
| J Voglová | 178 | 207 | 55 | 33 | 297 | |
| Simone Claudiani | 129 | 154 | 45 | 31 | 195 | |
| Carla Boquimpani | 191 | 220 | 106 | 29 | 228 | |
| Fabian Lang | 151 | 208 | 67 | 37 | 258 | |
| Daniela Žáčková | 130 | 163 | 51 | 33 | 195 | |
| Michelina Santopietro | 154 | 176 | 59 | 37 | 227 | |
| Cristina Bucelli | 153 | 158 | 70 | 33 | 227 | |
| Ekaterina Chelysheva | 91 | 169 | 83 | 32 | 222 | |
| Damien Luque Paz | 202 | 177 | 79 | 33 | 298 | |
| Daigo Akahane | 50 | 133 | 33 | 44 | 261 |
All Works
Login with ORCID to disown or claim papers
Loading papers...